Arcline Investment Management to Sell Medical Device Maker MMT for $685 Million

Arcline Investment Management to Sell MMT to Perimeter Solutions

In a significant move for the medical manufacturing sector, Arcline Investment Management, a private equity firm focused on growth, announced its agreement to sell its portfolio company, Medical Manufacturing Technologies (MMT), to Perimeter Solutions, Inc., for an impressive $685 million. This sale marks a notable moment in the evolving landscape of medical device manufacturing and underlines Arcline's strategic approach.

Overview of Medical Manufacturing Technologies

Based in Charlotte, North Carolina, MMT has established itself as a global leader in providing comprehensive manufacturing solutions specifically tailored for medical devices. The company excels in serving as a single-resource partner for customers engaging in automated and process-driven manufacturing. With its extensive experience, MMT caters to over 1,000 clients, including several prominent original equipment manufacturers (OEMs) and contract development and manufacturing organizations (CDMOs) within the industry. Its product offerings encompass complex interventional devices, such as catheters, guidewires, stents, microcoils, and various intricate components essential to medical practices.

With a robust workforce of over 350 employees and 14 specialized production facilities, MMT positions itself as a critical partner for those operating in precision-driven and heavily regulated environments. The company’s commitment to quality and efficiency has made it a preferred choice for many in the medical devices field.

Arcline’s Strategic Growth

Since acquiring MMT in 2020, Arcline has implemented a disciplined growth strategy aimed at fortifying MMT’s market position as a provider of essential manufacturing technologies for medical device OEMs and CDMOs. Under Arcline’s stewardship, MMT has seen significant revenue and EBITDA growth, indicative of successful operational enhancements.

To amplify its capabilities, MMT completed a total of 13 strategic acquisitions during Arcline’s ownership. These acquisitions were targeted to expand MMT’s service offerings, particularly in the realms of automation solutions and specialty manufacturing services. These enhancements are critical in streamlining and optimizing the complex production processes often required in medical device manufacturing.

Robbie Atkinson, MMT's Chief Executive Officer, along with his team, has been instrumental in executing this growth strategy, and Arcline expressed gratitude for their efforts and partnership throughout this journey.

Expectations and Impact of the Transaction

The transaction is anticipated to reach finalization in the first quarter of 2026, pending necessary regulatory approvals and standard closing conditions. The deal aligns with Perimeter Solutions’ goal of bolstering its production abilities in the medical space, showcasing a shared vision for advancing healthcare technologies.

Financial advisories for the transaction include prominent firms William Blair and Houlihan Lokey, while legal guidance was provided by the esteemed firms Kirkland & Ellis LLP alongside Fredrikson & Byron P.A. This transaction reiterates the increasing trend of consolidation within the medical manufacturing sector, hinting at a future where advanced technologies and manufacturing paradigms rapidly evolve to meet healthcare demands.

About Arcline Investment Management

Arcline Investment Management prides itself on being an influential player in private equity, managing over $20 billion in assets under management. The firm effectively looks to create the next generation of industrial platforms—termed ‘Industrial Compounders’—aiming for consistent growth and earnings in non-disruptive markets. For more details about Arcline and its investment strategies, visit www.arcline.com.

Through this sale, Arcline not only signifies a robust exit but also displays its capacity to nurture and grow companies within its portfolio, establishing landmarks in the domains of medical manufacturing and technological innovation.